サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1545512

ライフサイエンス機器の世界市場

Life Science Instrumentation

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ライフサイエンス機器の世界市場
出版日: 2024年09月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ライフサイエンス機器の世界市場は2030年までに1,040億米ドルに達する見込み

2023年に759億米ドルと推定されるライフサイエンス機器の世界市場は、2023年から2030年にかけてCAGR 4.6%で成長し、2030年には1,040億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである分光技術は、CAGR 4.7%を記録し、分析期間終了までに244億米ドルに達すると予測されます。クロマトグラフィー技術分野の成長率は、分析期間のCAGRで5.2％と推定されます。

米国市場は204億米ドルと推定、中国はCAGR4.3%で成長すると予測

米国のライフサイエンス機器市場は2023年に204億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに163億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは4.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.0%と3.9%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界のライフサイエンス機器市場- 主要動向と促進要因のまとめ

ライフサイエンス機器が科学研究の発展に不可欠な理由とは？

ライフサイエンス機器は、ゲノミクス、プロテオミクス、細胞生物学などの分野で精密で正確な実験を行うために必要なツールや技術を提供するため、科学研究の発展に不可欠です。質量分析計、クロマトグラフ、顕微鏡を含むこれらの機器は、研究者が生物学的サンプルを分子および細胞レベルで分析することを可能にし、疾病メカニズム、医薬品開発、個別化医療における新たな発見につながります。科学研究がますます複雑化し、データ集約型になるにつれ、高解像度で再現性の高い結果を提供できる高度な装置への需要が高まっており、ライフサイエンス機器は現代の研究所の要となっています。

技術革新はライフサイエンス機器市場をどのように牽引しているか？

技術革新は、ライフサイエンス機器市場を大きく前進させ、より洗練された汎用性の高い機器の開発につながっています。自動化とロボットの実験機器への統合により、効率とスループットが向上し、研究者は最小限の人的介入でハイスループットのスクリーニングと分析を実施できるようになっています。さらに、超解像顕微鏡やクライオ電子顕微鏡などのイメージング技術の進歩により、研究者は生物学的構造をかつてないほど詳細に可視化できるようになっています。ポータブルで小型化された装置の開発により、ライフサイエンス・ツールへのアクセスも拡大し、研究者は従来の研究室以外の場所でも実験を行えるようになっています。このような技術革新は、ライフサイエンス業界全体で先進的な機器の導入に拍車をかけています。

ライフサイエンス機器市場を形成している動向は？

個別化医療への注目の高まり、ハイスループットスクリーニングへの需要の高まり、合成生物学やCRISPR遺伝子編集などの新興分野における研究の拡大など、いくつかの主要動向がライフサイエンス機器市場を形成しています。個別化医療は、個々の遺伝子プロファイルや分子プロファイルの分析を必要とするため、精密で詳細な分析が可能な機器への需要が高まっています。特に創薬では、ハイスループットスクリーニングの動向が、大量のサンプルを迅速かつ正確に分析できる機器へのニーズを高めています。さらに、合成生物学や遺伝子編集の台頭は、研究者が遺伝物質を操作・研究するための専門的なツールを必要とするため、ライフサイエンス機器に新たな機会をもたらしています。こうした動向が、ライフサイエンス機器市場のダイナミックな成長に寄与しています。

ライフサイエンス機器市場の成長を促進する要因は？

ライフサイエンス機器市場の成長は、高度な研究ツールに対する需要の増加、個別化医療の台頭、ライフサイエンス業界における研究開発活動の拡大など、いくつかの要因によってもたらされています。慢性疾患の蔓延や新たな治療法の必要性の高まりは、生物医学研究への投資を促進し、その結果、高度な機器への需要が高まっています。さらに、ゲノミクス、プロテオミクス、メタボロミクスなどの分野における急速な進歩は、ライフサイエンス機器に新たな機会をもたらしています。また、自動化とハイスループット分析へのシフトも、研究室が効率改善とコスト削減を求めていることから、市場の成長を後押ししています。ライフサイエンス産業が進歩を続ける中、最先端機器への需要が市場の持続的成長を促進すると予想されます。

調査対象企業の例（注目の44社）

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Bruker Corporation
  • ChromaCode
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Hitachi High-Tech Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13012

Global Life Science Instrumentation Market to Reach US$104.0 Billion by 2030

The global market for Life Science Instrumentation estimated at US$75.9 Billion in the year 2023, is expected to reach US$104.0 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Spectroscopy Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$24.4 Billion by the end of the analysis period. Growth in the Chromatography Technology segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.4 Billion While China is Forecast to Grow at 4.3% CAGR

The Life Science Instrumentation market in the U.S. is estimated at US$20.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$16.3 Billion by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Life Science Instrumentation Market - Key Trends & Drivers Summarized

Why Is Life Science Instrumentation Critical to Advancing Scientific Research?

Life science instrumentation is critical to advancing scientific research as it provides the tools and technologies necessary for conducting precise and accurate experiments in areas such as genomics, proteomics, and cell biology. These instruments, which include mass spectrometers, chromatographs, and microscopes, enable researchers to analyze biological samples at the molecular and cellular levels, leading to new discoveries in disease mechanisms, drug development, and personalized medicine. As scientific research becomes increasingly complex and data-intensive, the demand for advanced instrumentation that can deliver high-resolution, reproducible results is growing, making life science instrumentation a cornerstone of modern research laboratories.

How Are Technological Innovations Driving the Life Science Instrumentation Market?

Technological innovations are driving significant advancements in the life science instrumentation market, leading to the development of more sophisticated and versatile instruments. The integration of automation and robotics into laboratory instruments is improving efficiency and throughput, allowing researchers to conduct high-throughput screening and analysis with minimal human intervention. Additionally, advancements in imaging technologies, such as super-resolution microscopy and cryo-electron microscopy, are enabling researchers to visualize biological structures in unprecedented detail. The development of portable and miniaturized instruments is also expanding the accessibility of life science tools, allowing researchers to conduct experiments outside of traditional laboratory settings. These technological innovations are fueling the adoption of advanced instrumentation across the life sciences industry.

What Trends Are Shaping the Life Science Instrumentation Market?

Several key trends are shaping the life science instrumentation market, including the increasing focus on personalized medicine, the growing demand for high-throughput screening, and the expansion of research in emerging fields such as synthetic biology and CRISPR gene editing. Personalized medicine, which requires the analysis of individual genetic and molecular profiles, is driving the demand for instruments that can perform precise and detailed analyses. The trend towards high-throughput screening, particularly in drug discovery, is increasing the need for instruments that can analyze large numbers of samples quickly and accurately. Additionally, the rise of synthetic biology and gene editing is creating new opportunities for life science instrumentation, as researchers require specialized tools to manipulate and study genetic material. These trends are contributing to the dynamic growth of the life science instrumentation market.

What Factors Are Driving the Growth of the Life Science Instrumentation Market?

The growth in the life science instrumentation market is driven by several factors, including the increasing demand for advanced research tools, the rise of personalized medicine, and the expansion of research and development activities in the life sciences industry. The growing prevalence of chronic diseases and the need for new therapies are driving investment in biomedical research, which in turn is increasing the demand for sophisticated instrumentation. Additionally, the rapid advancements in fields such as genomics, proteomics, and metabolomics are creating new opportunities for life science instruments. The shift towards automation and high-throughput analysis is also fueling market growth, as laboratories seek to improve efficiency and reduce costs. As the life sciences industry continues to advance, the demand for cutting-edge instrumentation is expected to drive sustained growth in the market.

Select Competitors (Total 44 Featured) -

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Bruker Corporation
  • ChromaCode
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Hitachi High-Tech Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Life Science Instrumentation - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Advanced Research and Diagnostics Spurs Growth in Life Science Instrumentation
    • Advancements in Analytical and Measurement Technologies Propel Adoption of Life Science Instruments
    • The Shift Towards Precision Medicine Expands Addressable Market for Life Science Instrumentation
    • Rising Focus on Genomics and Proteomics Drives Demand for Cutting-Edge Instruments
    • Growing Application of Life Science Instruments in Drug Discovery and Development Strengthens Market Demand
    • Technological Innovations in Mass Spectrometry and Chromatography Enhance Performance and Accuracy
    • Expanding Use of Life Science Instruments in Clinical Diagnostics Generates New Market Opportunities
    • The Push for High-Throughput Screening and Automation Fuels Adoption in Laboratories
    • Increasing Adoption of Life Science Instruments in Biotechnology and Pharmaceutical Industries Accelerates Market Expansion
    • Rising Importance of Real-Time and In Vivo Imaging Strengthens Demand for Advanced Instruments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Clinical & Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Clinical & Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Clinical & Diagnostic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Life Science Instrumentation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Life Science Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Life Science Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Life Science Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Spectroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Spectroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Spectroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Liquid Handling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Liquid Handling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Liquid Handling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Chemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinical Chemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Clinical Chemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Next-Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Next-Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Next-Generation Sequencing (NGS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Research Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Research Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Research Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Life Science Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Life Science Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Life Science Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Life Science Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Life Science Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Life Science Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Life Science Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Life Science Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Life Science Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Life Science Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Life Science Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Life Science Instrumentation by Application - Research Applications, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Life Science Instrumentation by Application - Percentage Breakdown of Value Sales for Research Applications, Clinical & Diagnostic Applications and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Life Science Instrumentation by Technology - Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of World 16-Year Perspective for Life Science Instrumentation by Technology - Percentage Breakdown of Value Sales for Spectroscopy, Chromatography, PCR, Liquid Handling, Clinical Chemistry Analyzers, Flow Cytometry, Next-Generation Sequencing (NGS) and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION